Gene: ZNF787
Official Full Name: zinc finger protein 787provided by HGNC
Gene Summary: Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27431 | ZNF787 Knockout cell line (HeLa) | Human | ZNF787 | 1:3~1:6 | Negative | Online Inquiry |
KO27432 | ZNF787 Knockout cell line (HCT 116) | Human | ZNF787 | 1:2~1:4 | Negative | Online Inquiry |
KO27433 | ZNF787 Knockout cell line (HEK293) | Human | ZNF787 | 1:3~1:6 | Negative | Online Inquiry |
KO27434 | ZNF787 Knockout cell line (A549) | Human | ZNF787 | 1:3~1:4 | Negative | Online Inquiry |
ZNF787 Gene Knockout Cell Lines are a specialized tool for research in genetic and cellular biology, designed to specifically disrupt the expression of the ZNF787 gene. This gene encodes a zinc finger protein, which plays a crucial role in various cellular processes, including transcriptional regulation, growth, and differentiation. By utilizing CRISPR-Cas9 or similar genome-editing technologies, these cell lines are engineered to create a complete knockout of the ZNF787 gene, allowing researchers to study the gene's function by analyzing the resulting phenotypic changes.
The primary function of ZNF787 gene knockout cell lines is to facilitate the exploration of ZNF787's biological roles in various cellular contexts, including oncogenesis and developmental biology. The knockout mechanism involves a targeted disruption that leads to the absence of ZNF787 protein synthesis, providing a system to investigate compensatory pathways and alternative molecular pathways activated due to its absence. These insights are critical for understanding the implications of ZNF787 in health and disease, particularly in cancer research where aberrant gene expressions are a hallmark.
The scientific importance of ZNF787 knockout cell lines can be seen in both basic research and clinical applications. Researchers are leveraging these cell lines to discover therapeutic targets, elucidate mechanisms of resistance to therapy, and identify biomarkers for disease progression. The genetic manipulation provided by these cell lines allows for detailed studies of gene interactions and regulatory networks, which can lead to breakthroughs in understanding complex biological processes.
What sets ZNF787 Gene Knockout Cell Lines apart from alternative products is their high specificity and validated performance in various applications. The meticulously characterized cell lines ensure reproducibility and reliability in experimental designs—features that are often lacking in conventional knockout models. Additionally, the ease of use in transfection protocols and their compatibility with a wide range of assays make these cell lines an invaluable resource for researchers.
For researchers and clinicians aiming to advance their studies or therapeutic strategies, ZNF787 Gene Knockout Cell Lines represent a foundational resource that fosters innovation and discovery. With a focus on quality and cutting-edge genetic techniques, our company specializes in providing high-fidelity biological products that support advancement in life sciences. Our product offerings emphasize research-driven solutions that empower the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.